Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Apr;61(4):770-774.
doi: 10.1007/s00125-018-4546-x. Epub 2018 Jan 21.

Organ donor pancreases for the study of human islet cell histology and pathophysiology: a precious and valuable resource

Affiliations
Editorial

Organ donor pancreases for the study of human islet cell histology and pathophysiology: a precious and valuable resource

Piero Marchetti et al. Diabetologia. 2018 Apr.

Abstract

Direct in vivo assessment of pancreatic islet-cells for the study of the pathophysiology of diabetes in humans is hampered by anatomical and technological hurdles. To date, most of the information that has been generated is derived from histological studies performed on pancreatic tissue from autopsy, surgery, in vivo biopsy or organ donation. Each approach has its advantages and disadvantages (as summarised in this commentary); however, in this edition of Diabetologia, Kusmartseva et al ( https://doi.org/10.1007/s00125-017-4494-x ) provide further evidence to support the use of organ donor pancreases for the study of human diabetes. They show that length of terminal hospitalisation of organ donors prior to death does not seem to influence the frequency of inflammatory cells infiltrating the pancreas and the replication of beta cells. These findings are reassuring, demonstrating the reliability of this precious and valuable resource for human islet cells research.

Keywords: Autoptic samples; Beta cells; Islet cells; Organ donors; Pancreatectomy; Pancreatic biopsies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no duality of interest associated with this manuscript.

Figures

Fig. 1
Fig. 1
Representative images, obtained by light or electron microscopy, of pancreatic samples yielded from organ donors. (a) Immunofluorescence analysis of an islet from a donor without diabetes; insulin containing cells are in red, glucagon containing cells are in green (M. Suleiman, personal communication). (b) Immunofluorescence analysis of an islet containing a beta cell with an apoptotic nucleus (white arrow); insulin containing cells are in red, the apoptotic nucleus is in green (TUNEL staining). Scale bars in (a) and (b), 20 μm. (c) An apoptotic beta cell visualised by electron microscopy; the yellow arrow indicates an apoptotic nucleus with marked chromatin condensation, the red arrows indicate insulin granules. Magnification ×10,000. (d, e) Electron micrograph showing immune cells infiltrating the pancreas. In (d), the yellow arrows indicate a macrophage and red arrows indicate insulin granules in a beta cell adjacent to the macrophage. In (e) the yellow arrow points to a mast cell. Scale bars in (d) and (e), 1 μm. (f) Electron micrograph showing a beta cell with signs of death associated with altered autophagy (note the cytoplasm engulfed with lysosomes [multigranular bodies]); the yellow arrow indicates the nucleus without evidence of apoptotic features, the red arrows point to some remaining insulin granules. Magnification ×7000. Figure parts (b), (d) and (e) adapted from [29] with permission from Springer Nature, copyright 2015; figure parts (c) and (f) adapted from [31] with permission from Springer Nature, copyright 2009

Comment on

References

    1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383:69–82. doi: 10.1016/S0140-6736(13)60591-7. - DOI - PMC - PubMed
    1. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239–2251. doi: 10.1016/S0140-6736(17)30058-2. - DOI - PubMed
    1. Halban PA, Polonsky KS, Bowden DW, et al. β-Cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab. 2014;99:1983–1992. doi: 10.1210/jc.2014-1425. - DOI - PMC - PubMed
    1. Marchetti P, Lupi R, Del Guerra S, et al. Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control. Diabetes Care. 2009;32(Suppl 2):S178–S183. doi: 10.2337/dc09-S306. - DOI - PMC - PubMed
    1. Eriksson O, Laughlin M, Brom M, et al. In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use. Diabetologia. 2016;59:1340–1349. doi: 10.1007/s00125-016-3959-7. - DOI - PubMed

LinkOut - more resources